Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques
about
sameAs
High-resolution magnetic resonance imaging: an emerging tool for evaluating intracranial arterial diseaseNon-invasive vulnerable plaque imaging: how do we know that treatment works?Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets.Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and ImagingHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesNanoparticles in magnetic resonance imaging: from simple to dual contrast agentsNew dual mode gadolinium nanoparticle contrast agent for magnetic resonance imagingRole of lipids in spheroidal high density lipoproteinsNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.MRI in Lower Extremity Peripheral Arterial Disease: Recent Advancements.Imaging atherosclerosis and vulnerable plaque.Progress in atherosclerotic plaque imaging.Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsionsNanomedicine strategies for molecular targets with MRI and optical imaging.Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.High-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agentsConquering the dark side: colloidal iron oxide nanoparticles.Imaging of atherosclerosisEmerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probeWash-free magnetic oligonucleotide probes-based NMR sensor for detecting the Hg ion.Imaging of atherosclerosis: magnetic resonance imaging.Quantitative cardiovascular magnetic resonance for molecular imaging.Nature-inspired nanoformulations for contrast-enhanced in vivo MR imaging of macrophages.Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release.(64)Cu-labeled LyP-1-dendrimer for PET-CT imaging of atherosclerotic plaqueLow-density lipoprotein nanoparticles as magnetic resonance imaging contrast agentsNon-invasive detection of vulnerable coronary plaque.Preparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cellsCerebrovascular MRI: a review of state-of-the-art approaches, methods and techniques.Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesRecombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.Utilizing imaging tools in lipidology: examining the potential of MRI for monitoring cholesterol therapy.Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.Strategies for Target-Specific Contrast Agents for Magnetic Resonance ImagingCharacterization and molecular detection of atherothrombosis by magnetic resonance--potential tools for individual risk assessment and diagnostics.
P2860
Q26863518-9C9188FF-2BF7-42E8-9BBF-08A59957E9DEQ27020959-401DEFD4-20C1-4851-8170-52AD037B7192Q27692593-5FC489D1-86DE-42DD-8702-6B32E5A298CFQ28070244-901BF1BD-7491-42E6-8428-A62584384A2EQ28077290-826E4715-25F2-4FAB-A30F-39800710BA54Q28082690-1AFD4DDE-0861-42A1-AB23-78985F89F88CQ28471645-87B96665-7AA4-4906-85A0-815ABC1B0623Q28475955-F7AD41A0-B009-42AB-9F18-D88A81ADD83FQ30354652-C00B0EC2-7FA6-48BC-847C-5245C52FE46AQ30361067-8A57443B-7FBB-43B2-A558-9863F627D554Q30414980-91DA878A-70C9-4F1B-BD1C-739FA5D5C4C9Q30435383-AFD7C27C-2061-447B-9C05-FC94460D4E1DQ30464390-449C3D94-C686-4B7E-A1BA-54E9A7DCF68CQ30474759-C8B24487-A3F0-4EBB-A524-EF4BB529F269Q30481471-65209905-58C3-4917-93E9-83873E89669BQ30484224-D7605041-B8B1-43BD-9023-7B92F5C1C7B4Q33429230-BECA7CD6-0BFA-4BF1-9B92-E9E9281E5FE8Q33554945-4EA1592E-45A5-4B85-82DD-022989594ACDQ33697215-F60066F6-284D-40D2-9F84-7CE77D80BBBBQ33839384-4B9F05BA-C060-4CBB-A8BC-3AA7E2CF1D6CQ33847006-972D8F70-9974-4C26-B0A9-894CE0B013FAQ33868758-F21A63BA-2B7A-4AE1-9F3C-FA1101BCEDC0Q34057876-B6BA054D-C3A9-46A8-ACFC-1B960F83985AQ34179702-4457B78C-32CF-45FF-8298-A6B1A65EF774Q34330885-5F79940F-6D6A-4124-871C-007154E34AA2Q34339353-2697EAAE-E8B5-4DA6-A94F-5BA401B552ACQ34736942-00D7864B-6A4D-4C03-B13A-97FA0E6C3A76Q34988879-FDC97208-A13D-43E5-9C54-988A41C04E8FQ35030851-AFAF902D-8CC6-46B6-9DEF-DCB612A188C7Q35082176-54CD72AA-9228-47D2-8249-25715DC35413Q35172896-22409931-D1D7-4441-90E7-E4C56D764601Q35577213-7110B476-044C-4B94-BE27-A522E356B61EQ35641545-DD1F9638-62C9-4796-B9C5-0F3B9D7821A9Q35667247-8713F948-AB1D-4038-81F7-2D536F4EFD0AQ35795262-C4D9833D-76F7-4CB4-B974-2D45A7916342Q36148570-D6A075F7-EE35-40DA-A177-E21B56ED6603Q36422755-81A5CACD-99A4-4188-B33A-E1626FD8A52CQ36434865-6DFDE96E-0040-4C6E-81B4-7BF40FD2B068Q36517070-A9561112-4578-4550-B877-0F137AD8B051Q36580339-9FB820BD-42DE-469C-84EA-9B954F90B236
P2860
Recombinant HDL-Like Nanoparticles: A Specific Contrast Agent for MRI of Atherosclerotic Plaques
description
im Dezember 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2004
@uk
name
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@en
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@nl
type
label
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@en
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@nl
altLabel
Recombinant HDL-like nanoparti ...... MRI of atherosclerotic plaques
@en
Recombinant HDL-like nanoparti ...... MRI of atherosclerotic plaques
@nl
prefLabel
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@en
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@nl
P2093
P50
P356
P1476
Recombinant HDL-Like Nanoparti ...... MRI of Atherosclerotic Plaques
@en
Recombinant HDL-like nanoparti ...... MRI of atherosclerotic plaques
@en
P2093
Edward A. Fisher
Zahi A Fayad
Zahi A. Fayad
P304
P356
10.1021/JA044911A
P407
P577
2004-12-01T00:00:00Z
2004-12-22T00:00:00Z